Skip to main content
. 2009 Jun 15;24(3):498–503. doi: 10.3346/jkms.2009.24.3.498

Fig. 1.

Fig. 1

The probability of leukemic free survival (LFS) and overall survival (OS) after FLAG chemotherapy in patients with relapsed or refractory AML (n=61).